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Abstract
Background: Primary cilia are flagella-like projections from the centriole of mammalian cells that
have a key role in cell signaling. Human diseases are linked to defects in primary cilia. Microtubules
make up the axoneme of cilia and are selectively acetylated and this is thought to contribute to the
stability of the structure. However, mechanisms to regulate tubulin acetylation in cilia are poorly
understood.
Results: Endogenous phosphatase inhibitor-2 (I-2) was found concentrated in cilia of human
epithelial cells, and was localized to cilia early in the process of formation, prior to the full
acetylation of microtubules. Knockdown of I-2 by siRNA significantly reduced the acetylation of
microtubules in cilia, without a net decrease in whole cell tubulin acetylation. There was a
reduction in the percentage of I-2 knockdown cells with a primary cilium, but no apparent
alteration in the cilium length, suggesting no change in microtubule-based transport processes.
Inhibition of either histone deacetylases with trichostatin A, or protein phosphatase-1 with
calyculin A in I-2 knockdown cells partially rescued the acetylation of microtubules in cilia and the
percentage of cells with a primary cilium.
Conclusion: The regulatory protein I-2 localizes to the primary cilium where it affects both Ser/
Thr phosphorylation and is required for full tubulin acetylation. Rescue of tubulin acetylation in I-2
knockdown cells by different chemical inhibitors shows that deacetylases and phosphatases are
functionally interconnected to regulate microtubules. As a multifunctional protein, I-2 may link cell
cycle progression to structure and stability of the primary cilium.
Background
Cilia are projections from the surface of cells that are sim-
ilar to flagella. The axoneme of a primary cilium is made
up of microtubules. Each cilium (and flagellum) grows
out from, and remains attached to, a basal body, which is
the maternal centriole [1]. Almost every cell in vertebrates
has a single primary cilium with a 9+0 arrangement [2],
which lacks the central pair of microtubules seen in the
9+2 arrangement of flagella and motile cilia. Primary cilia
are essential for several critical signaling pathways, sen-
sory reception and detection of fluid flow across epithelia.
Recent studies suggest that a variety of human syndromes
are related to defects in the assembly, maintenance and
function of the primary cilium, including renal dysfunc-
tion, diabetes, and retinal degeneration [3,4].
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Little is currently known about the control of the forma-
tion and resorption of cilia, although many proteins have
been defined as ciliary structural components or cilia-
associated signaling proteins. Several lines of evidence
indicate a relationship between cell cycle and primary cil-
ium assembly. Ciliary disassembly in many cells precedes
entry into the cell cycle and ciliary assembly follows exit
from mitosis [5,6]. Some proteins, such as NIMA-related
kinase [7] and Aurora kinase [8,9], have been shown to
play roles in both cell cycle regulation and assembly of
cilia.
Protein phosphatase 1 (PP1) is a major protein Ser/Thr
phosphatase with a variety of cellular functions [10-12].
PP1 exists in cells as a set of distinctive multisubunit
holoenzymes [12,13], which are comprised of a PP1 cata-
lytic subunit paired with a regulatory subunit. There are
predicted to be 200+ regulatory subunits that control PP1
holoenzyme subcellular localization, catalytic activity and
substrate specificity. Protein phosphatase inhibitor-2 (I-2)
is a heat stable protein capable of selectively inhibiting the
PP1 catalytic subunit [14]. Recent studies show that the
function of I-2 is important for the cell cycle regulation
and I-2 is localized at centrosomes during interphase [15].
The expression level of I-2 fluctuates during the cell cycle
and is enhanced at mitosis [16], when it becomes phos-
phorylated at PXTP site [17,18]. Knockdown of I-2 by
RNAi in mammalian cells leads to failure of cytokinesis
and formation of multinucleated cells, probably due to an
imbalance of Aurora B vs. PP1 [19]. During Drosophila
early embryogenesis, maternal I-2 is required for proper
chromosome segregation and mitotic synchrony [20]. The
concept is that I-2 selectively targets certain PP1 holoen-
zymes to control kinase/PP1 balance and thereby trigger
cellular events.
Here we report that endogenous I-2 is localized in the pri-
mary cilium of human retinal epithelial ARPE-19 cells.
During the process of cilium formation, I-2 was concen-
trated in the cilium before axonemal tubulin was
acetylated. Knockdown of I-2 by RNAi specifically
reduced tubulin acetylation in the primary cilium, not the
rest of the cell, and this could be rescued by chemical inhi-
bition of either PP1 or HDAC. Our results indicate that I-
2 has a role in regulation of tubulin acetylation in the pri-
mary cilium.
Results
Localization of I-2 in the primary cilium of human retinal 
pigment epithelial cells
We found using laser confocal fluorescent microscopy
that endogenous phosphatase inhibitor 2 (I-2) concen-
trated in the primary cilium of confluent human diploid
retinal epithelial ARPE-19 cells (Fig. 1). I-2 was concen-
trated in one short segment that stained more brightly
I-2 localization by specific antibody staining in human ARPE- 19 cells Figure 1
I-2 localization by specific antibody staining in human 
ARPE-19 cells. (A) Extracts from confluent ARPE-19 cells 
and MCF-7 cells were subjected to Western blotting using 
affinity-purified sheep antibody specific for human I-2. This 
antibody only recognized I-2, and its phosphorylated form 
(minor upper band) in both cell lines. (B) Confluent ARPE-19 
cells were fixed, and stained with anti-I-2 antibody as 
described under Methods. Compressed Z-stack of optical 
sections from laser confocal microscopy is shown. Scale bar 
= 20 micron.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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than the I-2 throughout the cytoplasm. Immunostaining
of the cells used an affinity-purified antibody that
detected a single protein corresponding to I-2 in whole
cell extracts of either ARPE-19 or human breast cancer
MCF-7 cells (Fig. 1A). A fraction of the I-2 in both cell
lines was phosphorylated, as seen by a minor band of
reduced mobility. In sub-confluent ARPE-19 cells endog-
enous I-2 co-localized with gamma-tubulin at the centro-
some (Fig. 2A–C), as we previously reported [15]. The
localization of I-2 was noticeably different after the cells
Co-localization of I-2 and tubulin in ARPE-19 cells Figure 2
Co-localization of I-2 and tubulin in ARPE-19 cells. ARPE-19 cells at sub confluent density were fixed and stained for I-2 
(A, green) and gamma-tubulin (C, red), and visualized by laser scanning confocal microscopy (merged image in B). Scale bar = 
20 micron. ARPE-19 cells 48 hrs after confluence were fixed and stained for I-2 (D, green) and acetylated tubulin (F, red) with 
merged image in E. Compressed Z-stack of confocal optical sections is displayed to show the primary cilia. Scale bar = 20 
micron. (G) Wide-field microscopic image to show localization of basal body (green, gamma-tubulin staining) and cilium 
(orange, acetylated-tubulin staining) in a confluent ARPE-19 cell. Scale bar = 25 micron. (H) Wide-field image to show the local-
ization of endogenous I-2 (green), gamma-tubulin (orange) and nucleus (blue) in confluent ARPE-19 cells. Scale bar = 25 
micron.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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became confluent (Fig. 2D–F). From the size, shape, and
location, we suspected the brightly stained structure in
each cell was the primary cilium, and confirmed this by
co-staining for acetylated tubulin (Fig. 2D–F). In hun-
dreds of cells, the cilia identified by anti-acetylated tubu-
lin were all brightly co-stained by anti I-2. Further
confirmation of these structures as primary cilia was based
on co-staining for gamma-tubulin and for acetylated
tubulin (Fig. 2G). The gamma-tubulin was localized at the
basal body (green) that served as the base for the cilium,
which contained acetylated tubulin (orange). Alternative
double staining of gamma-tubulin and I-2 revealed the
similar structure, with the gamma-tubulin (orange)
appearing at the base of the cilium stained with anti-I-2
(green) (Fig. 2H). Our conclusion from these results was
that phosphatase inhibitor 2 is localized at centrosomes
in sub-confluent interphase ARPE-19 cells, and becomes
concentrated in the primary cilium that extends from the
centriole after cells reach confluence.
Induction of primary cilium formation in ARPE-19 cells
To study how I-2 is involved in the primary cilium, we first
examined the kinetics of cilium formation in ARPE-19
cells grown under different conditions (Figure 3). Conflu-
ent monolayers of cells were cultured in 10% FBS or
serum-free medium for different periods of time, then
fixed and stained for acetylated tubulin to identify the pri-
mary cilium. Acetylated tubulin staining was bright in the
midbody of the few cells completing mitosis (Fig. 3A). At
24 hr post confluence, bright foci of acetylated tubulin
that were not previously detected appeared in about 1/3
of the cells, indicating formation of a primary cilium (Fig.
3B). At 48 hrs post confluence (Fig. 3C), continuing up to
7 days thereafter (Fig. 3D), > 60% of cells formed a pri-
mary cilium that was brightly stained for acetylated tubu-
lin. The kinetics of primary cilium formation in confluent
ARPE-19 cells was not different whether the cells were
incubated with or without 10% serum (data not shown).
However, removal of serum from the medium induced
formation of a primary cilium in sub-confluent cells (Fig.
3E).
Detection of I-2 and PP1 in isolated primary cilia
We confirmed the localization of endogenous I-2 in the
primary cilium by immunoblotting analysis of a cilia frac-
tion dissociated from cells using the calcium shock
method and recovered by differential ultracentrifugation.
Equivalent numbers of sub-confluent and post-confluent
cells were used as starting material in the cilia isolation
procedure. Immunoblotting showed that there were iden-
tical amounts of actin and PP1 in these samples (Fig. 4A).
Post-confluent cells had slightly lower levels of acetylated
tubulin and I-2 compared to sub-confluent cells (Fig. 4A).
The cilia fractions obtained from sub-confluent and post-
confluent cells were resolved by SDS-PAGE, and proteins
Kinetics of primary cilium formation in ARPE-19 cells Figure 3
Kinetics of primary cilium formation in ARPE-19 
cells. (A – D). ARPE-19 cells at different time points (0 hr, 24 
hrs, 48 hrs and 168 hrs) after confluence were fixed and 
stained for acetylated-tubulin (orange) and DNA (blue). Scale 
bar = 25 micron. (E) Sub-confluent ARPE-19 cells were incu-
bated with serum free medium for 48 hrs, fixed and stained 
for acetylated-tubulin (orange) and DNA (blue). Scale bar = 
25 micron.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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stained by Coomassie (Fig. 4B). Relatively few proteins
were recovered in the cilium fraction from sub-confluent
cells, whereas post-confluent cells yielded about a dozen
of prominent proteins of different sizes. Proteins recov-
ered in this cilia fraction represented selected enrichment
of a subset of the proteins present in a whole extract of
ARPE-19 cells. Immunoblotting identified acetylated
tubulin, PP1C and I-2 in the cilia fraction from post-con-
fluent cells that were not in the cilia fraction of sub-con-
fluent cells (Fig. 4C). These results showed that acetylated
tubulin, I-2 and PP1C were recovered in the primary cil-
ium by biochemical fractionation, which reinforces the
immunostaining of I-2 in the primary cilium of individual
cells.
I-2 concentrates in the primary cilium prior to tubulin 
acetylation
I-2 became concentrated in the primary cilium before the
appearance of acetylated tubulin (Fig. 5). This was a curi-
ous observation, because tubulin acetylation is com-
monly used to identify the primary cilium. Sub-confluent
cells showed diffuse cytoplamic distribution of acetylated
tubulin and endogenous I-2 by double immunofluores-
cent staining (Fig. 5A and 5B). Hours after the cells
became confluent, I-2 became concentrated into a struc-
ture that appeared to be the primary cilium, even though
the structure was not co-stained for acetylated tubulin at
this time (Fig. 5C and 5D). Later, after 48 hrs, confluent
ARPE-19 cells displayed a primary cilium that co-stained
for both I-2 and acetylated tubulin (Figure 5E and 5F).
The structures that initially formed hours after confluence
were co-immunostained for both I-2 and beta-tubulin
(Fig. 5G, H) showing these indeed were primary cilia,
even though they did not stain for acetylated tubulin. We
concluded that I-2 was recruited into the primary cilium
relatively early, preceding the accumulation of acetylated
tubulin.
I-2 is required for robust acetylation of tubulin in the 
primary cilium
We used siRNA transfection to knockdown the levels of
endogenous I-2 to study effects on the primary cilium.
Effective knockdown of I-2 required 24 hrs exposure to
siRNA prior to confluence and I-2 protein levels were
reduced by >85% compared to control siRNA transfected
cells (Fig. 6A). I-2 knockdown did not change the levels of
acetylated tubulin or PP1 in the cells, as determined by
immunoblotting (Fig. 6A). We discovered knockdown of
I-2 significantly reduced the fraction of cells with a pri-
mary cilium stained for acetylated tubulin, from 65% to
40% (Fig. 6C). Alternatively, staining for alpha-tubulin
gave the same reduction in the fraction cells with a pri-
mary cilium due to knockdown of I-2 (Fig. 6D and 6E).
Isolation and analysis of cilia fraction from ARPE-19 cells Figure 4
Isolation and analysis of cilia fraction from ARPE-19 
cells. (A) Western blot to show levels of acetylated tubulin, 
I-2, PP1C and actin in equal numbers of sub-confluent and 
confluent cells used to isolate a cilia fraction. (B) Sub-conflu-
ent and 48 hr post confluent cells were used in parallel for 
cilia isolation by Calcium Shock and ultracentrifugation. Equal 
volumes of the cilia fraction were analyzed by SDS-PAGE in 
12% gels stained with Commassie. (C) Western blotting to 
show the presence of I-2, PP1C and acetylated tubulin in the 
cilia fraction of sub-confluent cells and cells harvested 48 hrs 
after confluence.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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Endogenous I-2 concentrates in the primary cilium before alpha-tubulin acetylation Figure 5
Endogenous I-2 concentrates in the primary cilium before alpha-tubulin acetylation. (A – F): ARPE-19 cells were 
fixed before confluence (A and B), 10 hrs after confluence (C and D), and 48 hrs after confluence (E and F), then stained for 
DNA (blue) + acetylated-tubulin (orange) (A, C and E) and co-stained for endogenous I-2 (green) (B, D and F). In C and D, 
white arrows point to the primary cilia where I-2 was present but acetylated tubulin was not detected. (G and H): ARPE-19 
cells were fixed at 10 hrs after confluence, and triple stained for DNA (blue), beta-tubulin (orange) and endogenous I-2 (green). 
White arrow points to the primary cilia where both I-2 and beta-tubulin were present. Scale bars = 25 micron.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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More striking than a reduction in the fraction of cells with
a primary cilium was the reduction in the intensity of
tubulin acetylation due to knockdown of I-2. When the
axonemal tubulin was scored as either fully or partially
acetylated there was nearly 90% reduction in cells with
full tubulin acetylation in the primary cilium (Fig. 6B and
6C, solid bars). Thus, a major effect of siRNA knockdown
of I-2 was a reduction in the level of tubulin acetylation in
the primary cilium. This conclusion was verified by dou-
ble immunofluorescent staining of control siRNA and I-2
knockdown cells for acetylated tubulin and alpha-tubulin
(Fig. 7). Staining for alpha-tubulin was the same in con-
trol and I-2 knockdown cells (Fig. 7B, D), whereas the
staining for acetylated tubulin was markedly reduced due
to I-2 knockdown (Fig. 7A, C). I-2 knockdown did not
decrease tubulin acetylation in either the cytosol of inter-
phase cells or midbody of late mitotic cells (not shown).
This argues that the effects of I-2 knockdown on tubulin
acetylation were localized in the primary cilium, and not
broadcast throughout the cell. We noted that the primary
cilium in I-2 knockdown cells appeared to be approxi-
mately the same length as primary cilium in control cells
(see both Fig. 6 and 7). The length of the primary cilium
depends on the process of dynamic intraflagellar trans-
port along the axonemal microtubules. We concluded
that neither I-2 levels nor full tubulin acetylation were
critical for these transport processes.
To demonstrate that the phenotype of reduced tubulin
acetylation in the primary cilium was not due to the off-
target effects of RNAi, we used another pair of siRNA tar-
geting a different coding region of I-2. The knockdown
efficiency and the phenotype were the same (data not
shown). Alternatively, we combined siRNA transfection in
sub-confluent ARPE-19 cells with induction of the pri-
mary cilium by serum starvation. In this protocol the pri-
mary cilium is formed without signals from cell-cell
contacts that are formed during confluence. Knockdown
of I-2 in sub-confluent cells significantly decreased the
percentage of cells with a primary cilium and reduced
tubulin acetylation in the primary cilium (not shown).
Reduced tubulin acetylation by I-2 knockdown would be
expected to reduce axonemal microtubule stability, and
probably thereby result in the overall lower fraction of
cells with a primary cilium.
Reversal of I-2 knockdown phenotypes by inhibition of 
HDAC or PP1
We sought to obtain stringent proof of the specificity of
RNAi by rescue of the knockdown phenotypes by over-
expression of I-2, using an expression vector mutated to
avoid RNAi. We over-expressed silently mutated I-2 in
ARPE-19 cells, but found this severely reduced the per-
centage of confluent cells that formed a primary cilium
(not shown). Therefore, we had to adopt alternative
Knockdown of I-2 reduces axonemal alpha-tubulin acetyla- tion and primary cilium assembly Figure 6
Knockdown of I-2 reduces axonemal alpha-tubulin 
acetylation and primary cilium assembly. (A) Cells 
were incubated with control siRNA or I-2 siRNA at 24 hrs 
before confluence, and collected 48 hrs after confluence. 
Extracts were subjected to immunoblotting as described in 
Methods. Actin was used as loading control. (B) ARPE-19 
cells transfected with control siRNA or I-2 siRNA were fixed 
and stained for acetylated-tubulin (orange) and DNA (blue). 
Scale bar = 10 micron. (C) Quantitation of cells with a pri-
mary cilium. Cells with a primary cilium evidenced by 
acetylated-tubulin staining were scored in 200 cells per 
group. Intensity of tubulin acetylation in the primary cilium 
was measured as described in Methods. Solid bars represent 
percentage of cells possessing a primary cilium with full level 
of alpha-tubulin acetylation, whereas open bars represent 
percentage of cells possessing a primary cilium with reduced 
levels of tubulin acetylation. Data were plotted as mean ± SD 
of values from three independent experiments. (D) Cells 
transfected with control siRNA or I-2 siRNA were fixed and 
stained for alpha-tubulin (green). Scale bar = 10 micron. (E) 
Percentage of cells with a primary cilium based on alpha-
tubulin staining was scored in 200 cells per group. Results 
were plotted as mean ± SD of values from three independent 
experiments.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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approaches to rescue the reduced acetylation of tubulin
phenotype in I-2 knockdown cells.
One approach was to inhibit multiple HDACs using the
relatively non-specific inhibitor trichostatin A (TSA).
Treatment with TSA partially restored to 50% the fraction
of I-2 knockdown cells that formed a primary cilium, and
had more dramatic and significant effect in increasing to
> 30% the fraction of cells with full tubulin acetylation in
the primary cilium (Fig. 8). Thus, inhibition of HDACs
partially compensated for knockdown of I-2.
The other approach was to inhibit protein phosphatase
type-1 (PP1) and type 2A (PP2A) using the cell-permeable
compound calyculin A. Calyculin A is effective at
nanomolar doses and shows some preference for PP2A
over PP1 [21,22]. We tested a range of concentrations
from 0.1 to 2 nM, and found that at 0.5 nM calyculin A
there was partial rescue of I-2 knockdown cells in the frac-
tion of cells with a primary cilium and of tubulin acetyla-
tion in the primary cilium (Fig. 8). Treatment of cells with
the same doses of TSA or calyculin A without knockdown
of I-2 produced no significant change in the fraction of
cells with a primary cilium, and no change in tubulin
acetylation in the primary cilium (Fig. 8). These results
suggest that partial inhibition of PP1 was able to reverse
the effect of I-2 knockdown.
Discussion
This study shows that phosphatase inhibitor 2 (I-2) is
concentrated in the primary cilium of human epithelial
cells. We found endogenous I-2 localizes to the primary
cilium prior to acetylation of the axonemal tubulin that
serves as a marker for the primary cilium. Knockdown of
I-2 by siRNA significantly suppressed the full acetylation
of tubulin in the axoneme of the primary cilium, and
reduced the percentage of cells with a primary cilium.
These effects were rescued by pharmacological inhibition
of PP1 or HDACs. Our results link I-2 and PP1, proteins
involved in control of protein Ser/Thr phosphorylation,
to the acetylation of tubulin in the primary cilium. This
links two different systems of protein post-translational
modification in the primary cilium.
Tubulin acetylation and deacetylation are catalyzed by a
tubulin acetyltransferase and a specific histone/tubulin
deacetylase (HDAC). Acetylation stabilizes microtubules
[23], and the modification has been mapped to a single
residue K40 of alpha-tubulin [24,25]. However, the iden-
tity of the acetyltransferase reactive with this site is still
unknown. Among the multiple histone deacetylases,
HDAC-6 has been shown to interact with and catalyze
alpha tubulin K40 deacetylation [26,27]. HDAC-6 has
been proposed to destabilize microtubules of the
axoneme in the primary cilium and be regulated through
Immunofluorescent staining of alpha-tubulin and acetylated  tubulin in ARPE-19 cells Figure 7
Immunofluorescent staining of alpha-tubulin and 
acetylated tubulin in ARPE-19 cells. ARPE-19 cells 
transfected with control siRNA or I-2 siRNA were fixed and 
triple stained for acetylated-tubulin (orange), DNA (blue) 
and alpha-tubulin (green). I-2 knockdown cells (C and D) 
showed reduction in acetylation of axonemal tubulin com-
pared with control cells (A and B), without change in the 
staining of alpha-tubulin. Scale bar = 25 micron.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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Rescue of I-2 knockdown phenotype by chemical inhibition of PP1 or HDAC Figure 8
Rescue of I-2 knockdown phenotype by chemical inhibition of PP1 or HDAC. (A) ARPE-19 cells were transfected 
with siRNA as described in Figure 6. Cells were treated with 0.5 μM TSA or 0.5 nM calyculin A at 24 hr after siRNA transfec-
tion and 48 hrs later were fixed and immunostained for acetylated tubulin. Percentage of cells possessing a primary cilium with 
full or reduced levels of tubulin acetylation was counted as described in Figure 6. (B) Wide field images to show the acetylated 
tubulin staining (red) and DNA staining (blue) in cells treated with control siRNA, I-2 siRNA, I-2 siRNA + 0.5 nM calyculin A, 
or I-2 siRNA + 0.5 μM TSA. Scale bar represents 20 micron.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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phosphorylation involving Aurora A [9]. Previous results
have shown that histone deacetylases, such as HDAC-1,
HDAC-6, and HDAC-10 bind directly to the PP1 catalytic
subunit [28,29]. Inhibition of HDACs by TSA causes dis-
sociation of these HDAC-PP1 complexes, presumably
through a conformational change. [28]. On the other
hand, ATM dependent activation of PP1 by ionizing radi-
ation led to dissociation of HDAC-PP1 complexes and
dephosphorylation of HDAC-1, with an increase of
HDAC activity [29]. Phosphorylation of I-2 directly by
ATM is proposed to cause dissociation from PP1, account-
ing for PP1 activation by ionizing radiation [30]. Previous
results therefore established functional links between
PP1, HDAC-6 and I-2 and we suggest these are related to
acetylation of tubulin in the primary cilium of epithelial
cells.
PP1 was found in proteomic analysis of purified flagella
from Chlamydomonas [31] and isolated human ciliary
axonemes [32]. This supports the idea that PP1 regulates
Ser/Thr phosphorylation of proteins in flagella and cilia.
In addition, RT-PCR analysis showed that the levels of
PP1 mRNA increased by 1.9-fold upon deflagellation,
considered as evidence that PP1 is involved in flagellum
function in Chlamydomonas. PP1 co-purifies with micro-
tubules (MT) and binding to microtubules is mediated by
the MT-associated protein Tau [33]. MT-associated phos-
phoproteins that might be PP1 substrates include kinesin
and dynein motor complexes that are responsible for
intraflagellar transport (IFT). However, the lack of change
in size of the primary cilium in I-2 knockdown cells argues
that I-2 does not regulate PP1 holoenzymes that control
IFT. Altogether, various results point to some regulation of
microtubule function and axoneme organization by PP1.
In our experiments, inhibition of PP1 by 0.5 nM calyculin
A rescued the reduction of alpha-tubulin acetylation in
response to I-2 knockdown. Low doses of calyculin A are
known to selectively inhibit PP2A [22,34,35], and we
observed that they did not affect tubulin acetylation in the
primary cilium in ARPE-19 cells (not shown). High doses
of calyculin A were lethal to ARPE-19 cells. We surmised
that the intermediate dose of calyculin A we used was pro-
ducing selective but probably incomplete inhibition of
PP1. We propose that I-2 affects tubulin acetylation and
stabilization of the axoneme in the primary cilium by
inhibiting the activity of specific PP1 holoenzymes. I-2
knockdown did not affect overall acetylation of tubulin,
as detected by Western blotting whole cell extracts, or
tubulin acetylation in either cytoplasm or midbody, as
detected by immunostaining. We suspect that I-2 sensitive
PP1 holoenzymes are specifically concentrated in the
axoneme of the primary cilium to regulate ciliary alpha-
tubulin acetylation, possibly by control of HDAC-6 activ-
ity. Previous work indicated that PP1 is targeted to micro-
tubules by the protein Tau, however, Tau has not been
identified by proteomics in flagella from
Chlamydomonas or in axonemal fraction from cilia of
human cells. This suggests that PP1 and therefore I-2
might be targeted to the primary cilium by some other
PP1 regulatory subunit yet to be identified.
Taken in sum, our data suggest a model (Fig. 9) for the
regulation of tubulin acetylation by I-2 in the primary cil-
ium of human epithelial cells. Axonemal tubulin acetyla-
tion is a balance between tubulin acetyltransferase and
deacetylase. We propose that a HDAC forms a complex
with a PP1 holoenzyme that binds I-2. I-2 inhibits the PP1
activity, keeping HDAC in an inactive, phosphorylated
state. When I-2 is knocked down or dissociated from the
PP1-HDAC complex, an increase of PP1 activity leads to
dephosphorylation and activation of HDAC, favoring
deacetylation of tubulin and destabilization of the pri-
mary cilium axoneme. This model invokes phosphoryla-
tion to negatively regulate HDAC-6, but the opposite has
been suggested, i.e. HDAC-6 activation by phosphoryla-
tion. An alternative could be regulation of HDAC-6 by
binding to PP1 with I-2 acting as an allosteric modifier of
PP1 inhibition of HDAC-6. More detailed study of
HDAC6-PP1 complexes should distinguish between these
models.
Lastly, we have demonstrated unanticipated multifunc-
tionality of I-2 that will need to be reconciled into more
complex models. I-2 is a mitotic phosphoprotein sub-
Model for regulation of axonemal tubulin acetylation in the  primary cilium by PP1 and I-2 Figure 9
Model for regulation of axonemal tubulin acetylation 
in the primary cilium by PP1 and I-2. Axonemal tubulin 
acetylation is regulated by the balance of acetyltransferase 
(HAT) and deacetylases (HDACs). The tubulin-localized 
HDAC binds and interacts with MT-associated PP1. The 
activity of HDAC is negatively regulated by phosphorylation, 
so PP1 dephosphorylation produces activation. The presence 
of I-2 inhibits this PP1 holoenzyme and keeps the PP1-bound 
HDAC inactive. As a result the axonemal tubulin is highly 
acetylated and stabilized during formation of the primary cil-
ium. When I-2 is depleted or dissociated from PP1-HDAC 
complex, PP1 dephosphorylates and activates HDAC, and 
results in ciliary tubulin deacetylation and destabilization of 
the axoneme of the primary cilium. Inhibition of PP1 by caly-
culin A or inhibition of HDAC by TSA can compensate for 
the function of I-2 in this pathway to increase tubulin acetyla-
tion.BMC Cell Biology 2008, 9:62 http://www.biomedcentral.com/1471-2121/9/62
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strate of CDK1-cyclin B1 [17,18]. In addition, I-2 binds
and regulates the Pin1 prolyl isomerase [36]. Both Nek2A
and Aurora A kinases are activated by I-2, the former indi-
rectly by PP1 inhibition, the latter directly by protein-pro-
tein interaction [37,38]. In separate studies we have found
that I-2 is required for proper chromosome segregation
and cytokinesis, probably by indirect control of Aurora B
[19]. Thus, I-2 has proved to be quite a versatile protein.
The primary cilium may take advantage of I-2 to connect
and coordinate different signaling pathways.
Conclusion
Results of this study show that protein acetylation and
phosphorylation are functionally interconnected to regu-
late the axonemal microtubules in the primary cilium.
The regulatory protein I-2 localizes to the primary cilium
prior to tubulin acetylation. Knockdown of I-2 by siRNA
significantly reduced tubulin acetylation selectively in the
primary cilium and chemical inhibitors of HDACs or PP1
partially reversed the effects of knockdown, showing that
I-2 affects both phosphorylation and acetylation. As a
mitotic phosphoprotein with multiple activities, I-2 may
link cell cycle progression to the structure and function of
the primary cilium.
Methods
Cell culture and transfection
Human adult retinal pigment epithelial cells (ARPE-
19)(ATCC #CRL-2302) were grown according to ATCC
recommendations. Cells were transfected with siRNA (80
nM) using Oligofectamine (Invitrogen) following the
manufacturer' instructions. In the presence of serum,
siRNA were incubated with cells 24 hrs prior to conflu-
ence to get efficient protein knockdown. Trichostatin A
(TSA) was purchased from Sigma. Calyculin A was bought
from Calbiochem. For the rescue assay, either 0.5 micro-
molar TSA or 0.5 nanomolar calyculin A was added into
medium 24 hrs after siRNA transfection.
siRNA preparation
Two pairs of siRNA targeting different coding regions of I-
2 were designed using Dharmacon program http://
www.dharmacon.com/, and ordered from Dharmacon
(Lafayette, Colorado). The sequences of siRNA are availa-
ble upon request.
Immunoblotting
Western blotting as described [39] used the following pri-
mary antibodies: sheep polyclonal anti-I-2 (1:500);
chicken anti-pan PP1 (1:20,000); mouse anti-actin
(1:1000) (Sigma); mouse anti-acetylated tubulin
(1:2000)(Sigma). Goat anti-rabbit Alexa Fluor 680, don-
key anti-sheep Alexa Fluor 680 were purchased from
Molecular Probes and Invitrogen and used at a 1:3000
dilution. Goat anti-mouse IRDye 800 and anti-chicken
IRDye 800 antibodies were purchased from Rockland
Immunochemicals and used at a 1:3000 dilution.
Microscopy
Immunofluorescent microscopy was done as described
[15] using the following primary antibodies: Sheep poly-
clonal anti-I-2 (1:100); Mouse anti acetylated-tubulin
(1:500) (Sigma); FITC-conjugated anti-alpha-tubulin;
mouse anti gamma-tubulin (1:1000) (Sigma); mouse anti
beta-tubulin (1:50) (DSHB). Rhodamine Red-X-conju-
gated goat anti-mouse, Oregon Green-conjugated goat
anti-rabbit or goat anti-sheep secondary antibodies were
used at 1:1000 (Molecular Probes). DNA was stained with
Hoechst 33342. Wide field images were obtained using
Nikon Eclipse E800 microscope equipped with a Hama-
matsu 3580 camera using OpenLab software 3.0. Confo-
cal images were obtained using an Olympus FluoView™
FV 1000 system.
Acetylated tubulin staining in cilia was analyzed with the
image-analysis software Openlab® (Improvision, Coven-
try, UK). A mask (ROI) was created around acetylated
tubulin staining in cilia. The mean pixel intensity of
actylated tubulin staining in the masked region was cor-
rected by subtracting background pixel intensity. A thresh-
old of pixel intensity was set based on the comparison of
staining intensity of control and I-2 knockdown cells.
Axonemal tubulin in cilium whose acetylated tubulin
staining intensity is above the threshold is counted as hav-
ing normal tubulin acetylation, otherwise is counted as
having inefficient tubulin acetylation.
Isolation of primary cilia fraction from ARPE19 cells
Primary cilia were isolated by Calcium Shock technique as
described [40].
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